Home > Products > APIs > Nintedanib Esylate
Nintedanib Esylate
  • Nintedanib EsylateNintedanib Esylate

Nintedanib Esylate

Nintedanib Esylate has in-house specification. DMF available.

CAS:656247-18-6

Model:656247-18-6

Send Inquiry

Product Description


CAS Number:656247-18-6

Molecular Formula:C31H33N5O4.C2H6O3S
Molecular Weight:649.75706

General Information

Nintedanib Esylate, a small molecule tyrosine kinase inhibitor TKI, is the result of a new study for the treatment of IPF.

It targets platelet-derived growth factor receptors (PDGF α and β), fibroblast growth factor receptors (FGFR1-3), and vascular endothelial growth factor receptors (VEGFR1-3), and binds competitively to the adenosine triphosphate (ATP) binding sites of these receptors, blocking the signaling pathways of the fibroblast process and inhibiting the proliferation, metastasis, and transformation of fibroblasts, thereby slowing the progression of IPF disease.

Regulations

Nintedanib Esylate has in-house specification. DMF approved.

 
Available Formulations
Capsule

Hot Tags: Nintedanib Esylate, China, Suppliers, Manufacturers, Factory

Product Tag

Related Category

Send Inquiry

Please Feel free to give your inquiry in the form below. We will reply you in 24 hours.